-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Rainbows and Unicorns: Pony Testing Co., Ltd. (SZSE:300887) Analysts Just Became A Lot More Optimistic
Rainbows and Unicorns: Pony Testing Co., Ltd. (SZSE:300887) Analysts Just Became A Lot More Optimistic
Pony Testing Co., Ltd. (SZSE:300887) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The analysts greatly increased their revenue estimates, suggesting a stark improvement in business fundamentals.
After the upgrade, the five analysts covering Pony Testing are now predicting revenues of CN¥3.3b in 2022. If met, this would reflect a notable 13% improvement in sales compared to the last 12 months. Statutory earnings per share are presumed to rise 9.9% to CN¥1.09. Before this latest update, the analysts had been forecasting revenues of CN¥3.0b and earnings per share (EPS) of CN¥0.99 in 2022. There has definitely been an improvement in perception recently, with the analysts substantially increasing both their earnings and revenue estimates.
View our latest analysis for Pony Testing
SZSE:300887 Earnings and Revenue Growth August 5th 2022Although the analysts have upgraded their earnings estimates, there was no change to the consensus price target of CN¥52.50, suggesting that the forecast performance does not have a long term impact on the company's valuation. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on Pony Testing, with the most bullish analyst valuing it at CN¥67.78 and the most bearish at CN¥44.28 per share. This shows there is still some diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.
Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. We would highlight that Pony Testing's revenue growth is expected to slow, with the forecast 27% annualised growth rate until the end of 2022 being well below the historical 82% growth over the last year. Compare this to the 44 other companies in this industry with analyst coverage, which are forecast to grow their revenue at 22% per year. Factoring in the forecast slowdown in growth, it looks like Pony Testing is forecast to grow at about the same rate as the wider industry.
The Bottom Line
The most important thing to take away from this upgrade is that analysts upgraded their earnings per share estimates for this year, expecting improving business conditions. There was also an upgrade to revenue estimates, although as we saw earlier, forecast growth is only expected to be about the same as the wider market. Some investors might be disappointed to see that the price target is unchanged, but we feel that improving fundamentals are usually a positive - assuming these forecasts are met! So Pony Testing could be a good candidate for more research.
These earnings upgrades look like a sterling endorsement, but before diving in - you should know that we've spotted 3 potential risks with Pony Testing, including concerns around earnings quality. For more information, you can click through to our platform to learn more about this and the 2 other risks we've identified .
Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies that insiders are buying.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
小马检测有限公司。(SZSE:300887)随着分析师大幅上调今年的预测,股东们今天将有理由微笑。分析师们大幅上调了营收预期,表明企业基本面出现了明显改善。
升级后,负责小马测试的五位分析师现在预测,2022年收入将达到33亿元人民币。如果得到满足,这将反映出与过去12个月相比,销售额显著提高了13%。法定每股收益预计增长9.9%,至1.09加元。在此次最新更新之前,分析师一直预测2022年收入为30亿加元,每股收益为0.99元。最近人们的看法肯定有所改善,分析师大幅提高了他们的收益和收入预期。
查看我们对小马测试的最新分析
深圳证交所:300887收益和收入增长2022年8月5日尽管分析师上调了盈利预期,但CN元52.50元的一致目标价没有变化,表明预测业绩不会对公司估值产生长期影响。然而,盯着一个单一的价格目标可能是不明智的,因为共识目标实际上是分析师价格目标的平均值。因此,一些投资者喜欢看看预估区间,看看对该公司的估值是否存在分歧意见。对于小马测试,有一些不同的看法,最乐观的分析师对其估值为67.78元人民币,最悲观的分析师估值为每股44.28元人民币。这表明,投资者的预期仍存在一定的差异,但分析师似乎并不是对该股的看法完全不同,好像这可能是一种成功或失败的局面。
从现在的大局来看,我们能够理解这些预测的方法之一,是看看它们如何与过去的业绩和行业增长预期相比较。我们要强调的是,Pony Testing的收入增长预计将放缓,截至2022年底的预测年化增长率为27%,远低于去年82%的历史增长率。相比之下,该行业其他44家分析师覆盖的公司预计收入将以每年22%的速度增长。考虑到增长放缓的预期,小马测试预计将以与整个行业大致相同的速度增长。
底线
此次上调最重要的一点是,分析师上调了对今年每股收益的预期,预计商业状况会有所改善。营收预期也有所上调,尽管正如我们早先看到的那样,预期增长仅与更广泛的市场大致相同。一些投资者可能会失望地看到目标价保持不变,但我们认为,基本面改善通常是积极的-假设这些预测得到满足!因此,小马测试可能是更多研究的一个很好的候选者。
这些收益上调看起来像是对英镑的认可,但在开始之前--你应该知道,我们已经发现了小马测试的3个潜在风险,包括对收益质量的担忧。欲了解更多信息,您可以点击我们的平台,了解更多关于这一风险和我们确定的其他两个风险的信息。
搜索有趣的公司的另一种方式可能是到达拐点是跟踪管理层是在买入还是在卖出,我们的免费内部人士正在收购的成长型公司名单。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧